Executive Activity at Processa Pharmaceuticals Indicates Continued Stake in Company
Sian Bigora, Chief Development Officer at Processa Pharmaceuticals, Inc., recently acquired common stock through a transaction reported to the Securities and Exchange Commission. This purchase occurred despite the company's shares having declined significantly over the past six months. The filing details her direct acquisition of 1,971 shares value…